References
- León B, López-Bravo M, Ardavín C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 2007; 26:519 - 31; http://dx.doi.org/10.1016/j.immuni.2007.01.017; PMID: 17412618
- Robbins SH, Walzer T, Dembélé D, Thibault C, Defays A, Bessou G, et al. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol 2008; 9:R17; http://dx.doi.org/10.1186/gb-2008-9-1-r17; PMID: 18218067
- Segura E, Touzot M, Bohineust A, Cappuccio A, Chiocchia G, Hosmalin A, et al. Human inflammatory dendritic cells induce th17 cell differentiation. Immunity 2013; 38:336 - 48; http://dx.doi.org/10.1016/j.immuni.2012.10.018; PMID: 23352235
- Satpathy AT, Kc W, Albring JC, Edelson BT, Kretzer NM, Bhattacharya D, et al. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J Exp Med 2012; 209:1135 - 52; http://dx.doi.org/10.1084/jem.20120030; PMID: 22615127
- Crozat K, Guiton R, Contreras V, Feuillet V, Dutertre CA, Ventre E, et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J Exp Med 2010; 207:1283 - 92; http://dx.doi.org/10.1084/jem.20100223; PMID: 20479118
- Hu Y, Shen F, Crellin NK, Ouyang W. The IL-17 pathway as a major therapeutic target in autoimmune diseases. Ann N Y Acad Sci 2011; 1217:60 - 76; http://dx.doi.org/10.1111/j.1749-6632.2010.05825.x; PMID: 21155836
- Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140:883 - 99; http://dx.doi.org/10.1016/j.cell.2010.01.025; PMID: 20303878
- Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012; 491:254 - 8; PMID: 23034650